Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 362.80
Bid: 361.60
Ask: 362.00
Change: 0.00 (0.00%)
Spread: 0.40 (0.111%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 362.80
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

$170m US new business contract win

20 Nov 2023 07:00

RNS Number : 9069T
QinetiQ Group plc
20 November 2023
 

News release

 

QinetiQ Group plc

$170m US new business contract win underpins Avantus growth

20 November 2023 - QinetiQ Group plc ("QinetiQ") is pleased to announce that it has won a 5-year $170m contract with the US Department of Homeland Security for the Tethered Aerostat Radar System (TARS).

 

TARS is the largest new business competitive win for Avantus since our acquisition last year and builds on recent significant contract awards, reported in our Interim Results last week. This win takes the total new contract awards this year for Avantus to $827m, equivalent to more than 2.5x years of revenue cover. These major contract wins deliver new incremental business, building momentum to deliver strong revenue growth in the second half of this year and beyond, underpinning our confidence that Avantus will deliver double-digit revenue growth at stable margin into the medium term.

Avantus has transformed our customer access in the US, expanding our customer base and creating a disruptive mid-tier business in the US. During the first half of the year, we have also identified new business opportunities worth an additional $1.5bn over the next five years, created through the combination of capabilities across the US and our other markets to drive our future growth plan.

TARS provides detection, tracking and monitoring capabilities in diverse environments at and beyond the US borders. Under this 5-year contract, QinetiQ will deliver aerostat operations, air-surface radar operations, ground control and data networking systems monitoring, and data analysis in support of border security and air sovereignty missions. The programme will be delivered through the provision of mission support, operations and maintenance, and lifecycle and programme management.

Steve Wadey, Group Chief Executive Officer of QinetiQ, said:

"Winning TARS is another significant and exciting milestone in the US - a clear demonstration of Avantus delivering growth. TARS is an integral part of our customer's mission to protect the US border and a critical capability to US national security. This win further reinforces our growth plan for Avantus and our wider business in the US."

About QinetiQ

QinetiQ is an integrated global defence and security company focused on mission-led innovation. QinetiQ employs circa 8,500 highly-skilled people, committed to creating new ways of protecting what matters most; testing technologies, systems, and processes to make sure they meet operational needs; and enabling customers to deploy new and enhanced capabilities with the assurance they will deliver the performance required. Visit our website www.QinetiQ.com.

For further information please contact:

John Haworth, Group Director Investor Relations:

+44 (0) 7920 545841

Lindsay Walls, Group Director Communications (Media enquiries):

+44 (0) 7793 427582

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTUKVAROSUAAUA
Date   Source Headline
18th Oct 20174:46 pmRNSHolding(s) in Company
10th Oct 20174:03 pmRNSHolding(s) in Company
10th Oct 201712:39 pmRNSDirector/PDMR Shareholding
6th Oct 20174:35 pmRNSHolding(s) in Company
29th Sep 20177:00 amRNSPre-Close Trading Statement
22nd Sep 20178:08 amRNSDirector/PDMR Shareholding
12th Sep 20172:08 pmRNSDirector/PDMR Shareholding
8th Sep 201710:43 amRNSDirector/PDMR Shareholding
5th Sep 20171:51 pmRNSHolding(s) in Company
4th Sep 20171:02 pmRNSDirector/PDMR Shareholding
4th Sep 201710:27 amRNSHolding(s) in Company
23rd Aug 201712:02 pmRNSHolding(s) in Company
22nd Aug 20174:19 pmRNSHolding(s) in Company
14th Aug 20173:52 pmRNSDirector/PDMR Shareholding
26th Jul 201712:23 pmRNSDirector/PDMR Shareholding
25th Jul 20173:43 pmRNSDirector/PDMR Shareholding
25th Jul 20179:41 amRNSDirector/PDMR Shareholding
24th Jul 20175:09 pmRNSDirector/PDMR Shareholding
24th Jul 20172:31 pmRNSDirector/PDMR Shareholding
21st Jul 201711:18 amRNSDirector/PDMR Shareholding
19th Jul 20174:05 pmRNSAGM Statement
19th Jul 20177:00 amRNSFirst Quarter Trading Update
13th Jul 20173:30 pmRNSDirector/PDMR Shareholding
11th Jul 20174:15 pmRNSDirector/PDMR Shareholding
7th Jul 20174:13 pmRNSAnnual Financial Report
23rd Jun 20179:40 amRNSDirector/PDMR Shareholding
21st Jun 20175:08 pmRNSDirector/PDMR Shareholding
13th Jun 20173:55 pmRNSAnnual Financial Report
12th Jun 20172:56 pmRNSDirector/PDMR Shareholding
25th May 20177:00 amRNSFull Year Results 2017
10th May 20174:00 pmRNSDirector/PDMR Shareholding
5th May 20174:42 pmRNSBlock listing Interim Review
12th Apr 20174:12 pmRNSDirector/PDMR Shareholding
31st Mar 20173:03 pmRNSTotal Voting Rights
28th Mar 20171:47 pmRNSTransaction in Own Shares 27 Mar 17 - Replacement
27th Mar 20175:48 pmRNSTransaction in Own Shares
24th Mar 20175:13 pmRNSTransaction in Own Shares
23rd Mar 20175:34 pmRNSTransaction in Own Shares
22nd Mar 20175:45 pmRNSTransaction in Own Shares
21st Mar 20175:31 pmRNSTransaction in Own Shares
20th Mar 20175:18 pmRNSTransaction in Own Shares
17th Mar 20175:53 pmRNSTransaction in Own Shares
16th Mar 20175:49 pmRNSTransaction in Own Shares
10th Mar 20173:17 pmRNSDirector/PDMR Shareholding
1st Mar 20177:00 amRNSTotal Voting Rights
27th Feb 20175:01 pmRNSTransaction in Own Shares
24th Feb 20175:09 pmRNSTransaction in Own Shares
23rd Feb 20175:08 pmRNSTransaction in Own Shares
22nd Feb 20175:20 pmRNSTransaction in Own Shares
21st Feb 20175:12 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.